Sudeep Pharma Limited · CashKonnect

About

Sudeep Pharma Limited manufactures and sells excipients and specialty ingredients for the pharmaceutical, food, and nutrition industries in India, the United States, and internationally. The company provides mineral salts, such as iron, calcium, sodium, zinc, copper, magnesium, manganese, potassium, picolinates, simethicone, and others;It also offers micronutrient premixes and liposomal, encapsulated ingredients, spray-dried formats, granulated ingredients, and triturated for sports nutrition, medical and clinical nutrition, infant nutrition, beverages, fortified staples, functional foods, and dairy products. In addition, the company provides a range of mineral powders and granules for carbonated, non-carbonated, and nutraceutical beverages; tricalcium phosphate, dicalcium phophate, dipotassium phosphate, ferric pyrophosphate, and disodium phosphate. Sudeep Pharma Limited was incorporated in 1989 and is based in Vadodara, India.

Key Metrics

as of Sep 2026

Market Cap14,985 Cr

P/E82.00

Div Yield0.11 %

Book Value₹78.20

52w High₹1,357.00

52w Low₹524.00

Face Value₹1.00

Quarterly Results

Rs. Crores · hover row for definition

Metric	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Sales	106.00	80.00	90.00	88.00	80.00	105.00	83.00
Expenses	66.00	51.00	61.00	57.00	50.00	59.00	57.00
Operating Profit	39.00	29.00	30.00	31.00	30.00	45.00	26.00
OPM %	37.00	36.00	33.00	35.00	38.00	43.00	32.00
Other Income	10.00	10.00	9.00	13.00	7.00	3.00	2.00
Depreciation	2.00	2.00	2.00	2.00	2.00	2.00	2.00
Interest	2.00	2.00	1.00	2.00	1.00	2.00	1.00
Profit before tax	45.00	35.00	37.00	40.00	34.00	45.00	26.00
Tax %	26.00	26.00	27.00	25.00	26.00	27.00	21.00
Net Profit	34.00	26.00	27.00	30.00	25.00	33.00	21.00
EPS in Rs	3.00	2.28	2.38	3.06	2.59	3.41	2.12

Profit & Loss

Annual · Rs. Crores

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Sales	339.00	357.00	344.00	404.00	345.00	218.00
Expenses	218.00	224.00	211.00	315.00	277.00	172.00
Operating Profit	120.00	133.00	133.00	89.00	68.00	46.00
OPM %	36.00	37.00	39.00	22.00	20.00	21.00
Other Income	38.00	8.00	8.00	11.00	8.00	4.00
Interest	7.00	6.00	4.00	5.00	2.00	1.00
Depreciation	7.00	6.00	5.00	5.00	4.00	4.00
Profit before tax	145.00	129.00	132.00	91.00	70.00	45.00
Tax %	26.00	26.00	26.00	26.00	26.00	22.00
Net Profit	108.00	96.00	98.00	67.00	52.00	35.00
EPS in Rs	9.52	9.85	696.05	476.69	371.23	248.31
Dividend Payout %	0.00	0.00	0.00	0.00	0.00	0.00

Balance Sheet

Annual · Rs. Crores — latest first

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Equity Capital	11.00	10.00	1.00	1.00	1.00	1.00
Reserves	775.00	418.00	333.00	235.00	167.00	115.00
Borrowings	127.00	123.00	60.00	71.00	73.00	31.00
Other Liabilities	61.00	54.00	56.00	109.00	92.00	67.00
Total Liabilities	974.00	604.00	451.00	416.00	333.00	214.00
Fixed Assets	102.00	105.00	96.00	90.00	120.00	68.00
CWIP	161.00	88.00	44.00	26.00	4.00	23.00
Investments	32.00	32.00	29.00	19.00	15.00	24.00
Other Assets	679.00	380.00	282.00	282.00	194.00	99.00
Total Assets	974.00	604.00	451.00	416.00	333.00	214.00

Cash Flows

Annual · Rs. Crores — latest first

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Cash from Operating Activity	96.00	59.00	59.00	42.00	-5.00	36.00
Cash from Investing Activity	-367.00	-92.00	-41.00	-41.00	-28.00	-45.00
Cash from Financing Activity	242.00	54.00	-16.00	-10.00	40.00	13.00
Net Cash Flow	-28.00	22.00	2.00	-9.00	7.00	4.00
Free Cash Flow	30.00	-2.00	27.00	4.00	-62.00	24.00
CFO/OP %	111.00	67.00	72.00	72.00	17.00	101.00

Ratios

Annual · Days / % — latest first

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Debtor Days	86.00	166.00	150.00	114.00	130.00	97.00
Inventory Days	463.00	199.00	131.00	115.00	71.00	66.00
Days Payable	151.00	110.00	99.00	86.00	65.00	73.00
Cash Conversion Cycle	399.00	255.00	182.00	143.00	136.00	90.00
Working Capital Days	240.00	140.00	125.00	57.00	37.00	15.00
ROCE %	21.00	29.00	39.00	35.00	37.00	—